| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | Isosorbide Mononitrate Extended-Release Tablets, USP | 1 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS USP 20 mEq K Rx Only 173714 | 1 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | These highlights do not include all the information needed to use divalproex sodium delayed-release tablets, USP safely and effectively. See full prescribing information for divalproex sodium delayed-release tablets, USP. DIVALPROEX sodium delayed-release tablets, USP for oral use Initial U.S. Approval: 1983 | 1 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | Carbamazepine Tablets USP, (Chewable), 100 mg and 200 mg Carbamazepine Tablets USP, 200 mg Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg, and 400 mg Carbamazepine Oral Suspension USP, 100 mg/5 mL | 1 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS USP 20 mEq K Rx Only 173714 | 2 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | Carbamazepine Tablets USP, (chewable), 100 mg and 200 mg Carbamazepine Tablets USP, 200 mg Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg, and 400 mg Carbamazepine Oral Suspension USP, 100 mg/5 mL | 3 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | FERROUS SULFATE ENTERIC-COATED TABLETS | 3 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | Carbamazepine Tablets USP, (chewable), 100 mg and 200 mg Carbamazepine Tablets USP, 200 mg Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg, and 400 mg Carbamazepine Oral Suspension USP, 100 mg/5 mL | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | PRESCRIBING INFORMATION Ranitidine Tablets USP, 150 mg and 300 mg | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | FERROUS SULFATE ENTERIC-COATED TABLETS | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | These highlights do not include all the information needed to use carisoprodol safely and effectively. See full prescribing information for carisoprodol tablets, USP. Carisoprodol Tablets, USP for Oral use CIV Initial U.S. Approval: 1959 | 1 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | These highlights do not include all the information needed to use lamotrigine extended-release tablets safely and effectively. See full prescribing information for lamotrigine extended-release tablets. Lamotrigine Extended-Release Tablets Initial U.S. Approval: 1994 | 1 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | AMRIX ® (Cyclobenzaprine Hydrochloride Extended-Release Capsules) | 3 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | These highlights do not include all the information needed to use verapamil hydrochloride extended-release capsules (PM) safely and effectively. See full prescribing information for verapamil hydrochloride extended-release capsules (PM). Verapamil Hydrochloride Extended-release Capsules (PM) (Controlled Onset) for Oral use Initial U.S. Approval: 1998 | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ff374897-6078-4061-be9c-0b880595ab1f | 1 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | Drug Facts | 1 | |
| Diethyl Phthalate | INACTIVE INGREDIENT | UF064M00AF | 8a023942-01e8-4849-aa3c-1a640ffc7fd3 | 7 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | a6b1858a-e796-4cb0-8a4d-d5c521874e84 | 1 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | b8ca1d80-6ea9-4a3f-ab06-beedf845de8f | 1 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | CARBAMAZEPINE TABLETS USP 200 mg Rx only | 2 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | AMRIX ® (Cyclobenzaprine Hydrochloride Extended-Release Capsules) | 1 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | 6c826b0a-ac87-48cc-a780-9a4a2118e8a8 | 1 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | Drug Facts | 3 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | AMRIX (CYCLOBENZAPRINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3862 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3612 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | AMRIX (CYCLOBENZAPRINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3486 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3413 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 16 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | RAZADYNE (GALANTAMINE HYDROBROMIDE) CAPSULE, EXTENDED RELEASE RAZADYNE (GALANTAMINE HYDROBROMIDE) SOLUTION RAZADYNE (GALANTAMINE HYDROBROMIDE) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] | 14 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | VERAPAMIL HYDROCHLORIDE PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 14 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | INDERAL XL (PROPRANOLOL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [MIST PHARMACEUTICALS, LLC] | 13 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | VIDEX EC (DIDANOSINE) CAPSULE, DELAYED RELEASE [BRISTOL-MYERS SQUIBB COMPANY] | 13 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | AMRIX (CYCLOBENZAPRINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [CEPHALON, INCORPORATED] | 12 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | EMBEDA (MORPHINE SULFATE AND NALTREXONE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC] | 12 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [UPSHER-SMITH LABORATORIES, INC.] | 10 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | RABEPRAZOLE SODIUM (RABEPRAZOLE) TABLET, DELAYED RELEASE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | SULFASALAZINE DELAYED-RELEASE (SULFASALAZINE) TABLET, DELAYED RELEASE [QUALITEST PHARMACEUTICALS] | 10 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [ACTAVIS KADIAN LLC] | 9 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | DIDANOSINE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 8 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | INNOPRAN XL (PROPRANOLOL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AKRIMAX PHARMACEUTICALS, LLC] | 8 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 8 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC] | 7 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | CARBAMAZEPINE TABLET, CHEWABLE CARBAMAZEPINE TABLET [CARDINAL HEALTH] | 6 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [WATSON LABORATORIES, INC.] | 6 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | QUDEXY XR (TOPIRAMATE) CAPSULE, EXTENDED RELEASE [UPSHER-SMITH LABORATORIES, INC.] | 6 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | CARBAMAZEPINE TABLET, CHEWABLE CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, EXTENDED RELEASE CARBAMAZEPINE SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | DIDANOSINE (DIDANOSINE ENTERIC-COATED BEADLETS) CAPSULE, DELAYED RELEASE [MYLAN PHARMACEUTICALS INC.] | 5 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [CITRON PHARMA LLC] | 5 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | GALANTAMINE HYDROBROMIDE TABLET, FILM COATED GALANTAMINE HYDROBROMIDE CAPSULE, EXTENDED RELEASE [PATRIOT PHARMACEUTICALS, LLC] | 5 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [CLINICAL SOLUTIONS WHOLESALE] | 5 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | TOPIRAMATE CAPSULE, EXTENDED RELEASE [UPSHER-SMITH LABORATORIES, INC.] | 5 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | DILTIAZEM HCL CD (DILTIAZEM HYDROCHLORIDE) CAPSULE, COATED, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] | 4 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 4 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 4 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ISOSORBIDE MONONITRATE TABLET, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 4 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | MAJOR RANITIDINE MAXIMUM STRENGTH (RANITIDINE) TABLET [MAJOR PHARMACEUTICALS] | 4 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 4 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [EURAND, INC.] | 4 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ACID REDUCER (RANITIDINE) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION] | 3 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ACID REDUCER MAXIMUM STRENGTH (RANITIDINE) TABLET [L. PERRIGO COMPANY] | 3 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | CARBAMAZEPINE TABLET [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | CARBAMAZEPINE TABLET, EXTENDED RELEASE [CARDINAL HEALTH] | 3 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | DG HEALTH ACID REDUCER (RANITIDINE) TABLET [DOLGENCORP INC] | 3 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ISOSORBIDE MONONITRATE TABLET, EXTENDED RELEASE [MAJOR PHARMACEUTICALS] | 3 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ISOSORBIDE MONONITRATE TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED] | 3 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 3 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | KADIAN ER (MORPHINE SULFATE) CAPSULE [ST MARYS MEDICAL PARK PHARMACY] | 3 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | LAMOTRIGINE TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED] | 3 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.] | 3 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRECKENRIDGE PHARMACEUTICAL, INC.] | 3 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | RANITIDINE (RANITIDINE HYDROCHLORIDE) TABLET [WOCKHARDT USA LLC.] | 3 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ROPINIROLE TABLET, FILM COATED, EXTENDED RELEASE [SANDOZ INC] | 3 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.] | 3 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ACID REDUCER (RANITIDINE) TABLET [MEIJER DISTRIBUTION INC] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ACID REDUCER (RANITIDINE) TABLET [RITE AID CORPORATION] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ACID REDUCER (RANITIDINE) TABLET [RITE AID CORPORATION] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ACID REDUCER (RANITIDINE) TABLET [SAFEWAY] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ACID REDUCER MAXIMUM STRENGTH (RANITIDINE) TABLET [HYVEE INC] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ACID REDUCER MAXIMUM STRENGTH (RANITIDINE) TABLET [MEIJER DISTRIBUTION INC] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | BEING WELL HEARTBURN RELIEF ACID REDUCER (RANITIDINE) TABLET [SAVE-A-LOT FOOD STORES LTD] | 2 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | CARBAMAZEPINE TABLET [REMEDYREPACK INC. ] | 2 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | CARBAMAZEPINE TABLET [UPSHER-SMITH LABORATORIES, INC] | 2 | |
| diethyl phthalate | INACTIVE INGREDIENT | UF064M00AF | CARDIZEM CD (DILTIAZEM HYDROCHLORIDE) CAPSULE, COATED, EXTENDED RELEASE [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | CAREONE ACID REDUCER (RANITIDINE) TABLET [AMERICAN SALES COMPANY] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | DG HEALTH ACID REDUCER MAXIMUM STRENGTH (RANITIDINE) TABLET [DOLGENCORP INC] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE (DILTIAZEM HYDROCHLORIDE) CAPSULE [CARDINAL HEALTH] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | FERROUS SULFATE TABLET [PADDOCK LABORATORIES, LLC] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | FORMU CARE RANITIDINE (RANITIDINE) TABLET [ACCESS BUSINESS GROUP LLC] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | GALANTAMINE HYDROBROMIDE CAPSULE, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | GOOD NEIGHBOR PHARMACY ACID CONTROL (RANITIDINE) TABLET [AMERISOURCE BERGEN] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | GOOD NEIGHBOR PHARMACY ACID CONTROL 150 MAXIMUM STRENGTH (RANITIDINE) TABLET [AMERISOURCE BERGEN] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | HEALTHY ACCENTS RANITIDINE (RANITIDINE) TABLET [DZA BRANDS LLC] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ISOSORBIDE MONONITRATE TABLET, EXTENDED RELEASE [CARDINAL HEALTH] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | LAMOTRIGINE TABLET, EXTENDED RELEASE [WOCKHARDT USA LLC.] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | LEADER ACID CONTROL MAXIMUM STRENGTH (RANITIDINE) TABLET [CARDINAL HEALTH] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | MAXIMUM STRENGTH (RANITIDINE) TABLET [PUBLIX SUPER MARKETS INC] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | PANCRELIPASE CAPSULE, DELAYED RELEASE [KAISER FOUNDATION HOSPITALS] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [AMERICAN HEALTH PACKAGING] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [ST MARYS MEDICAL PARK PHARMACY .] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [UNIT DOSE SERVICES] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | RABEPRAZOLE SODIUM TABLET, DELAYED RELEASE [TORRENT PHARMACEUTICALS LIMITED] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | RANITIDINE HYDROCHLORIDE TABLET [REMEDYREPACK INC. ] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | RX ACT HEARTBURN RELIEF (RANITIDINE) TABLET [H E B] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | SMART SENSE ACID REDUCER (RANITIDINE) TABLET [KMART CORPORATION] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | SUNMARK ACID REDUCER MAXIMUM STRENGTH (RANITIDINE) TABLET [MCKESSON] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | TOPCARE HEARTBURN RELIEF 150 (RANITIDINE) TABLET [TOPCO ASSOCIATES LLC] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | WAL ZAN 75 (RANITIDINE) TABLET [WALGREEN COMPANY] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | WAL ZAN ACID REDUCER MAXIMUM STRENGTH (RANITIDINE) TABLET [WALGREEN COMPANY] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ACID REDUCER (RANITIDINE) TABLET [HANNAFORD BROTHERS COMPANY] | 1 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ACID REDUCER (RANITIDINE) TABLET [HYVEE INC] | 1 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ACID REDUCER (RANITIDINE) TABLET [SHOPKO STORES OPERATING CO., LLC] | 1 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | ACID REDUCER (RANITIDINE) TABLET [SHOPKO STORES OPERATING CO., LLC] | 1 | |